Evidence map›Paper›PMID 30205287›Full record

ArticleBrain and language2018

Quantitative assessment of grammar in amyloid-negative logopenic aphasia.

Katerina A Tetzloff, Jennifer L Whitwell, Rene L Utianski, Joseph R Duffy, Heather M Clark, Mary M Machulda, Edythe A Strand, Keith A Josephs

Open access · greenAbstract read
In one paragraph

Article in Brain and language, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Katerina A TetzloffDepartment of Radiology, Mayo Clinic, Rochester, MN, United States.
Jennifer L WhitwellDepartment of Radiology, Mayo Clinic, Rochester, MN, United States. Electronic address: whitwell.jennifer@mayo.edu.
Rene L UtianskiDepartment of Neurology (Division of Speech and Language Pathology), Mayo Clinic, Rochester, MN, United States.
Joseph R DuffyDepartment of Neurology (Division of Speech and Language Pathology), Mayo Clinic, Rochester, MN, United States.
Heather M ClarkDepartment of Neurology (Division of Speech and Language Pathology), Mayo Clinic, Rochester, MN, United States.
Mary M MachuldaDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
Edythe A StrandDepartment of Neurology (Division of Speech and Language Pathology), Mayo Clinic, Rochester, MN, United States.
Keith A JosephsDepartment of Neurology (Division of Behavioral Neurology and Movement Disorders), Mayo Clinic, Rochester, MN, United States.
Mayo Clinic · USMayo Clinic in Arizona · USWinnMed · US

Funding

Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)R01DC012519 · NIDCD · MAYO CLINIC ROCHESTER · PI Jennifer Louise Whitwell · 2013 to 2026
$7.2M
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal studyR01AG050603 · NIA · MAYO CLINIC ROCHESTER · PI WHITWELL, JENNIFER LOUISE · 2016 to 2025
$5.9M
Longitudinal Multi-modal Imaging in Progressive Supranuclear Palsy SyndromesR01NS089757 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A, WHITWELL, JENNIFER LOUISE · 2015 to 2024
$5.6M
PIB PET Scanning in Speech and Language Based DementiasR01DC010367 · NIDCD · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2010 to 2014
$1.7M
Assessment of hyperphosphorylated tau PET binding in primary progressive aphasiaR21NS094684 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2016 to 2017
$417k
NIA NIH HHS R01 AG050603NIDCD NIH HHS R01 DC010367NIDCD NIH HHS R01 DC012519NINDS NIH HHS R01 NS089757NINDS NIH HHS R21 NS094684
6 · The paper itself

Abstract

Logopenic primary progressive aphasia (lvPPA) typically results from underlying Alzheimer's disease, but subjects have been reported that do not show beta-amyloid (Aβ) deposition. These subjects do not differ on neurological and speech-language testing from Aβ-positive lvPPA, but they impressionistically show increased grammatical deficits. We performed a quantitative linguistic analysis of grammatical characteristics in Aβ-negative lvPPA compared to Aβ-positive lvPPA and agrammatic PPA, which is characterized by increased grammatical difficulties. Aβ-negative lvPPA used fewer function words and correct verbs but more syntactic and semantic errors compared to Aβ-positive lvPPA. These measures did not differ between Aβ-negative lvPPA and agPPA. Both lvPPA cohorts showed a higher mean length of utterance, more complex sentences, and fewer nouns than agPPA. Aβ-negative lvPPA subjects appear unique and share linguistic features with both agPPA and Aβ-positive lvPPA. Quantitative language analysis in lvPPA may be able to distinguish those with and without Aβ deposition.

Indexed as

SemanticsAgedAlzheimer DiseaseAphasia, Primary ProgressiveFemaleHumansLanguage TestsMaleMiddle AgedSpeech PerceptionAgrammatismAmyloidAphasiaLogopenicLogopenic aphasiaPETPrimary progressive aphasiaSyntax

Identifiers

PMID30205287
PMCPMC6299833
OpenAlexW2892067517

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.